U.S. CDMRP – Peer Reviewed Medical Research Program | Research Funding
Event details
| Date | 29.03.2023 |
| Category | Call for proposal |
Aim: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the Peer Reviewed Medical Research Program (PRMRP) Awards.
All applications for PRMRP funding must specifically address at least one of the Topic Areas as directed by Congress and have direct relevance to military health. Several award programs are available:
Funding: Discovery Award – max. $200K
Investigator-Initiated Research Award – $1.6M - $2M
Focused Program Award – max. $7.2M
Clinical Trial Award – No pre-determined ceiling
Technology Therapeutic Development Award – max. $2M
Duration: Discovery Award – 2 years
Investigator-Initiated Research Award – 4 years
Focused Program Award – 4 years
Clinical Trial Award – 4 - 5.5 years
Technology Therapeutic Development Award – 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible for the Discovery Award. All investigators at or above the level of assistant professor (or equivalent) are eligible for the Investigator-Initiated, Clinical Trial, and Technology Development Awards. All investigators at or above the level of full professor (or equivalent) are eligible for the Focused Program Award.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Grants.gov Funding Opportunity Numbers:
Pre-Application Deadline: (1) March 29, 2023 (5:00 p.m. Eastern time)
(2) April 12, 2023 (5:00 p.m. Eastern time)
(3) April 19, 2023 (5:00 p.m. Eastern time)
Full Application Deadline: Opportunity-dependent
Further information
All applications for PRMRP funding must specifically address at least one of the Topic Areas as directed by Congress and have direct relevance to military health. Several award programs are available:
- The Discovery Award supports innovative, non-incremental, high-risk/potentially high-reward research. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation.
- The Investigator-Initiated Research Award supports studies that will make an important contribution toward research and/or patient care for a disease or condition related to one of the FY23 PRMRP Topic Areas. Supported research should have the potential to yield highly impactful data that could lead to critical discoveries or major advancements.
- The Focused Program Awards are intended to optimize research and accelerate solutions to a critical question related to one of the congressionally directed FY23 PRMRP Topic Areas through a synergistic, multidisciplinary research program. Applications shall include multiple, distinct research projects led by individual project leaders (minimum 4 projects).
- The Clinical Trial Awards support the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in one of the congressionally directed FY23 PRMRP Topic Areas.
- The Technology Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the FY23 PRMRP Topic Areas.
Funding: Discovery Award – max. $200K
Investigator-Initiated Research Award – $1.6M - $2M
Focused Program Award – max. $7.2M
Clinical Trial Award – No pre-determined ceiling
Technology Therapeutic Development Award – max. $2M
Duration: Discovery Award – 2 years
Investigator-Initiated Research Award – 4 years
Focused Program Award – 4 years
Clinical Trial Award – 4 - 5.5 years
Technology Therapeutic Development Award – 4 years
Eligibility: Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible for the Discovery Award. All investigators at or above the level of assistant professor (or equivalent) are eligible for the Investigator-Initiated, Clinical Trial, and Technology Development Awards. All investigators at or above the level of full professor (or equivalent) are eligible for the Focused Program Award.
How to Apply: Pre-applications are submitted through the eBRAP platform. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace. Application packages can be downloaded from Grants.gov at any time.
Grants.gov Funding Opportunity Numbers:
- Discovery Award – HT9425-23-PRMRP-DA (1)
- Investigator Initiated Research Award – HT9425-23-PRMRP-IIRA (3)
- Focused Program Award – HT9425-23-PRMRP-FPA (2)
- Clinical Trial Award – HT9425-23-PRMRP-CTA (2)
- Technology Therapeutic Development Award – HT9425-23-PRMRP-TTDA (3)
Pre-Application Deadline: (1) March 29, 2023 (5:00 p.m. Eastern time)
(2) April 12, 2023 (5:00 p.m. Eastern time)
(3) April 19, 2023 (5:00 p.m. Eastern time)
Full Application Deadline: Opportunity-dependent
Further information
- To find the full program announcements, use the opportunity-specific links above to connect to Grants.gov
- For questions about the eBRAP or Grants.gov platforms, contact the Research Office.
Practical information
- General public
- Free